In a study of more than 4000 subjects, elevated cholesterol levels were found to be associated with an increased risk of renal dysfunction in apparently healthy men
Read More »Systolic BP Predicts Diabetic Nephropathy Progression
Findings provide strong support for aggressive BP reduction for people with nephropathy from type 2 diabetes.
Read More »Issue 166 Item 8 ACE Inhibitors Prevent Diabetes and Cardiovascular Disease by D
Angiotensin-converting enzyme (ACE) inhibitors improve markers of cardiovascular disease and prevent diabetes, renal disease, and cardiovascular disease.
Read More »Issue 166 Item 9 Randomized Trial Demonstrates Benefits of Lifestyle Modificatio
First randomised trial ever to report that people who have a high risk of developing type 2 diabetes mellitus can prevent the disease.
Read More »Issue 166 Item 10 New Discovery May Unravel the Holy Grail of Obesity
New Protein Identified Which Can Possibly Unlock The Treatment For Obesity
Read More »Issue 166 Item 11 Repaglinide – Metformin Combo Is Safe and Effective for Type 2
Patients who received repaglinide/metformin treatment had lower final HbA1c values than those who received nateglinide/metformin.
Read More »Issue 166 Item 12 DHEA Use Enhances Endothelial Function and Insulin Sensitivity
New study findings indicate that replenishment of this hormone with supplements can improve endothelial function and insulin sensitivity-which may lower the risk of heart disease.
Read More »Issue 166 Item 13 Glucosamine Supplementation Does Not Impair Glucose Control
Glucosamine supplementation does not cause clinically significant changes in glucose metabolism in patients with type 2 diabetes.
Read More »Issue 166 Item 14 Insurers To Reward Patients for Losing Weight. & Exercising
Human Services Secretary Tommy Thompson wants Insurance companies to give discounts to customers who lose weight and exercise every day and the U.S. government plans to help them do it.
Read More »Issue 166 Item 15 Teens With Type 1 Diabetes Benefit From Metformin
Metformin as adjunctive therapy for adolescents with type 1 diabetes and insulin resistance lowered hemoglobin A1c levels and decreased insulin dosage with no weight gain.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.